HCA Healthcare target price increased - HCA Healthcare (NYSE: HCA) price increased to $ 186.00 by JPMorgan Chase & Co analysts

HCA Healthcare (NYSE: HCA) raised its target price for JPMorgan Chase & Co Research Analysts from $ 157.00 to $ 186.00 in a report released on Friday, reports BenzingaRatingsTable. The brokerage currently has an "overweight" rating on the stock. JPMorgan Chase & Co's target price suggests a potential upside of 25.62% from the company's previous close.

HCA has been the subject of several other reports. Barclays increased their target price on HCA Healthcare from $ 145.00 to $ 155.00 and gave the company an “overweight” rating in a report on Wednesday, October 30th. Bank of America upgraded HCA Healthcare from a “neutral” rating to a “buy” rating in a research note on Friday, December 6th. Finally, ValuEngine upgraded HCA Healthcare from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Two equities research analysts have rated the holdings with a hold rating and thirteen have assigned a buy rating to the company shares. The company currently has an average rating of “Buy” and a consensus target price of $ 157.86.

HCA Healthcare target price increased

Shares of HCA stock opened at $ 148.06 on Friday. The firm has a market capitalization of $ 48.64 billion, a P / E ratio of 15.15, a price-to-earnings-growth ratio of 1.21 and a beta of 0.91. The business has a 50-day moving average price of $ 139.12 and a two-day moving average price of $ 130.59. HCA Healthcare has a 12 month low of $ 110.31 and a 12 month high of $ 146.96.

HCA Healthcare (NYSE: HCA) last released its quarterly earnings results on Tuesday, October 29th. The company reported $ 2.23 EPS for the quarter, beating the Zacks ’consensus estimate of $ 2.13 by $ 0.10. The company had revenue of $ 1269 billion during the quarter, compared to analyst estimates of $ 12.48 billion. HCA Healthcare had a net margin of 6.98% and a negative return on equity of 173.49%. The company's revenue was up 10.9% compared to the same quarter last year. During the same period last year, the business posted $ 2.16 EPS. On average, equities research analysts expect that HCA Healthcare will post $ 10.53 earnings per share for the current fiscal year.

In related news, Senior Vice President Christopher F. Wyatt sold 3,900 shares of the company’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $ 134.74, for a total transaction of $ 525,486.00. Following the completion of the transaction, the senior vice president now owns 27,353 shares in the company, valued at approximately $ 3,685,543.22. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Jon M. Foster sold 19,477 shares of the company’s stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $ 132.35, for a total value of $ 2,577,780.95. Following the completion of the transaction, the insider now directly owns 10,015 shares in the company, valued at approximately $ 1,325,485.25. The disclosure of this sale can be found here. Insiders have sold a total of 42,620 shares of the company’s stock worth $ 5,725,883 during the last quarter. 2.70% of the stock is currently owned by insiders.

Institutional investors and hedge funds have recently made changes in their positions in the stock. Penserra Capital Management LLC purchased a new position in HCA Healthcare in the third quarter worth approximately $ 26,000. Doyle Wealth Management bought a new stake in shares of HCA Healthcare in the second quarter worth $ 34,000. Prime Capital Investment Advisors LLC bought a new position in shares of HCA Healthcare during the third quarter worth $ 39,000. North Star Investment Management Corp bought a new position in shares of HCA Healthcare during the third quarter worth $ 42,000. Finally, Coastal Investment Advisors Inc bought a new position in shares of HCA Healthcare during the third quarter worth $ 42,000. Institutional investors own 69.41% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc., through its subsidiaries, provides health care services. The company operates general care hospitals that offer medical and surgical services, which include hospitals.